BIOQ BIOQUAL, Inc. featured news, full reports, and detailed charts
BIOQUAL, Inc. (BIOQ/BIOQ.PK) Wrap Up:
Bioqual, Inc., through its subsidiary, Enhanced Therapeutics, Inc., provides research, development, and consulting services to government and commercial contract clients. It offers research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, transgenics, contraception, breeding and development of genetically defined animals, and neurobiology and behavior. The company, through government contracts, engages in infectious disease investigations, cancer research, and various other studies, including good laboratory practice documentation and conditions. It also offers laboratory services to evaluate immunologic, virologic, and molecular biologic parameters in animal models u...BIOQUAL, Inc. (BIOQ:OTC)
|
Market Cap
11.4M
|
Total Revenue
27.0M
|
|
|
EBITDA
2.7M
|
DILUTED EPS TTM
1.28
|
|
|
P/E
9.8x
|
P/S
0.4x
|
|
|
Return On Asset
10.20
|
Return On Equity
12.19
|
|
| K = Thousands M = Millions B = Billions | ||
BIOQ Top Compensated Officers
Executives, Board Directors
Key developments for BIOQUAL, Inc. (BIOQ)
BIOQUAL, Inc. reported earnings results for the full year 2009. For the year, the company reported income before income tax of $2,219,052 and net income of $1,322,209 or $1.46 per diluted share on revenues of $28,247,895 compared to the income before income tax of $1,961,937 and net income of $1,207,930 or $1.34 per diluted share on revenues of $24,868,256 for the previous year. The company's board of directors has declared a dividend of $0.16 per share for shareholders of record on September 16, 2009, payable on October 7, 2009. This is the ninth dividend declared by company.
BIOQUAL Inc. announced earnings results for the fiscal year 2008. For the year, the company reported net income of $1,207,930 or $1.35 per share on revenues of $24,868,256 compared to net income of $1,075,971 or $1.21 per share on revenues of $21,869,066 for the previous year. The company Board of Directors has declared a dividend of $0.16 per share for shareholders of record on September 9, 2008, payable on September 30, 2008.
BIOQ Competitors
| Company | Last | Change | |
| No competitor information is available for BIOQ. | |||
| Market data is delayed at least 20 minutes. | |||
Industry Analysis
| Valuation | BIOQ | Industry Range |
| Price/Earnings | 9.8x |
|
| Price/Sales | 0.4x |
|
| Price/Book | 1.1x |
|
| Price/Cash Flow | 9.8x |
|
| TEV/Sales | 0.3x |
|
|
BIOQ |
||
BIOQ transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent News About BIOQUAL, Inc.
More news for BIOQ
BIOQUAL Presents Financial Results for Fiscal Year 2009 and Declares Dividend
  2009 2008  Revenue $ 28,247,895 $ 24,868,256  Income Before Income Tax $ 2,219,052 $ 1,961,937  Net Income $ 1,322,209 $ 1,207,930  Basic Earnings per Share of Common Stock $ ...Click here to read the whole Article (external link)